The invention consists of a diagnostic / prognostic method for identifying, from a blood sample, patients at low-risk and high-risk of developing colorectal cancer from a blood sample.
| Patent title | Prognostic method |
|---|---|
| Thematic area | Health |
| Ownership | ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA |
| Inventors | Gabriella Mattei, Maria Teresa Rodia, Luigi Ricciardiello, Isacco Montroni, Rossella Solmi, Giampaolo Ugolini, Mattia Lauriola |
| Filed on | 12 January 2018 |
Over the past decade, huge efforts have been made by the scientific community to develop new and powerful tools for cancer screening and detection. This applies to colorectal cancer (CRC) in particular, since it arises as a consequence of genetic and molecular alterations of the nascent tumour, which develop over time.
A panel of four mRNAs has been invented as a promising tool for the detection of patients with high-risk lesions, as well as low risk patients from healthy subjects, a gold standard for early detection.
In the biomedical field, for the prognosis of patients at low-risk and high-risk of developing colorectal cancer.